SURF vs MNOV
Comparison between Surface Oncology Inc (SURF, Company) and Medicinova Inc (MNOV, Company).
5-Year PerformanceMNOV has outperformed SURF, delivering a return of -18.9% compared to -36.3%
SURF vs MNOV - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
SURF vs MNOV - Historical Returns
Returns include dividend reinvestment.
SURF vs MNOV - Annual Returns (2006 - 2026)
Returns include dividend reinvestment.
| Year | SURF | MNOV |
|---|---|---|
| 2026 | N/A | -0.75% |
| 2025 | N/A | -38.50% |
| 2024 | N/A | +27.27% |
| 2023 | +31.24% | -30.88% |
| 2022 | -83.86% | -26.26% |
| 2021 | -47.65% | -49.15% |
| 2020 | +394.12% | -21.26% |
| 2019 | -56.78% | -17.80% |
| 2018 | -68.19% | +23.79% |
| 2017 | N/A | +5.55% |
| 2016 | N/A | +66.57% |
| 2015 | N/A | +7.58% |
| 2014 | N/A | +38.18% |
| 2013 | N/A | +30.49% |
| 2012 | N/A | -6.29% |
| 2011 | N/A | -64.95% |
| 2010 | N/A | -31.54% |
| 2009 | N/A | +342.77% |
| 2008 | N/A | -65.43% |
| 2007 | N/A | -67.14% |
| 2006 | N/A | +9.75% |
SURF vs MNOV Drawdown Comparison
The maximum drawdown for SURF was -96.80%, occurring on Apr 27, 2023. This drawdown has not yet recovered.
The maximum drawdown for MNOV was -92.09%, occurring on Aug 7, 2024. This drawdown has not yet recovered.
The current SURF drawdown is -94.00%. The current MNOV drawdown is -90.76%.
| Rank | SURF | MNOV |
|---|---|---|
| #1 | -96.80% Jul 9, 2018 - Apr 27, 2023 | -92.09% Dec 28, 2006 - Aug 7, 2024 |
| #2 | -14.81% May 2, 2018 - Jun 18, 2018 | -6.55% Dec 13, 2006 - Dec 21, 2006 |
| #3 | -10.05% Jun 25, 2018 - Jul 9, 2018 | -5.57% Dec 21, 2006 - Dec 28, 2006 |
| #4 | -6.73% Apr 20, 2018 - Apr 27, 2018 | -0.83% Dec 8, 2006 - Dec 12, 2006 |
| #5 | -5.13% Jun 18, 2018 - Jun 25, 2018 | N/A |
Correlation
Correlation between SURF and MNOV is 0.52 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks